Understanding Fetal Membrane Rupture Is Important to Improve the High Rate of Preterm Birth {#S1}
===========================================================================================

The human fetal membranes are an often-overlooked tissue by those studying the mechanisms of parturition. They are disregarded, as many consider that term fetal membranes are a dead tissue, or simply a membranous extension of the placenta. However, many researchers have successfully highlighted it's importance by culturing tissue explants ([@B182]; [@B7]) and isolated cells ([@B71]; [@B140]), revealing its role as a complex conduit between the mother and fetus ([@B49]). It has a large surface area for signaling and clearly contributes to the inflammation that is an established signature of parturition ([@B139]), regardless of whether it is precipitated by infection ([@B46]).

Parturition involves several distinct, yet integrated, physiological events; cervical ripening and dilation, contractility of the myometrium, rupture of the membranes, placental separation and uterine involution ([@B29]). All of these processes need to occur in a coordinated manner for the successful delivery of the fetus at term. Thus, desynchrony or the dysregulation of these events can lead to Preterm Birth (PTB) via a number of different pathways ([@B45]). Approximately 20% of all preterm deliveries are by Cesarean section for maternal or fetal indications ([@B29]). Of the remaining cases, around a third are caused by premature preterm rupture of the membranes (pPROM), 20--25% result from intra-amniotic infection, and the remainder due to premature uterine contractions ([@B29]). However, approximately 60% of all preterm deliveries still remain unexplained ([@B29]). Epidemiological studies have suggested that preterm delivery is a condition that clusters in families ([@B154]), and that the incidence of pPROM and the other causes of PTB differ among ethnic groups ([@B90]). Although about 50% of all PTB is due to infection, antibiotics that successfully treat the infection do not halt PTB ([@B48]). Once the fetal membranes rupture, they are beyond rescue as there is no commonly used therapy to repair the ruptured regions, although some strategies like the Amniopatch appear promising ([@B31]). Thus, there is a need to improve our understanding of this phenomenon, so that we can identify two groups of pPROM patients, those at risk for pPROM after infection and those at risk for non-infectious pPROM. Compounding this intricate challenge is that there are gaps in our fundamental knowledge as to how the fetal membranes weaken at the end of a normal pregnancy. Our lack of understanding of how normal membrane rupture occurs, impedes our ability to determine how this normal mechanism digresses during pPROM.

The importance of finding new therapeutic targets for the prevention of PTB, and also improving our understanding of basic parturition mechanisms, including rupture of the fetal membranes cannot be overstated. This is because much of the impact of PTB in the United States is borne by our minority populations. Americans who are members of racial and ethnic minority groups, (African Americans, American Indians and Alaska Natives, Asian Americans, Hispanics or Latinos, Native Hawaiians, and other Pacific Islanders), are more likely than Caucasians to have poor health and to die prematurely ([@B23])^[1](#footnote1){ref-type="fn"}^. States that have the highest rates of PTB disparity typically have large minority populations. Indeed, data from the March of Dimes mirrors this, showing that Hawai'i was ranked the 50th state in terms of PTB as a health disparity (March of Dimes Perstats^[2](#footnote2){ref-type="fn"}^). The infant mortality rate is twice as high for Native Hawaiian mothers compared to whites and 43.9% of the cause of this infant mortality is PTB related ([@B54]). Contributing to the lack of progress in Hawai'i is the lack of ethnic disaggregation, masking valuable information ([@B118]; [@B167]) as many established health disparities, including PTB, differentially affect ethnic groups within this population pool ([@B17]). In addition, we have no data on specific incidence of pPROM, versus other etiologies of PTB, although it is frequently seen in the clinic. It is likely that this is due to the general lack of focus on the importance of the fetal membranes in pregnancy outcomes, that is also seen in the other states. In Hawaii, like the rest of the United States, African American mothers have the highest rates of prematurity (13.8%) (March of Dimes Perstats: see text footnote 2). However, they only constitute 2.2% of the population (United States census data^[3](#footnote3){ref-type="fn"}^). In other United States states African Americans constitute a much larger percentage of the population and consistently have the highest prematurity rate ([@B141]). These studies are typically controlled for socioeconomic and demographic confounders and therefore to improve our understanding of the underlying cause, future studies need to focus on determining the risk factors for specific ethnic groups.

The Onset of Fetal Membrane Weakening May Be Triggered by Cellular Stress {#S2}
=========================================================================

One of the fundamental remaining questions in the field of parturition research is how the tissues of pregnancy switch from a relatively "quiescent" state that favors the maintenance of the pregnancy, to one that is "reactive" in preparation for the delivery of the fetus. Animals other than humans and non-human primates experience a drop-in progesterone level but this does not appear to happen in the same way in humans ([@B95]). In order to increase our understanding of the differences in the mechanism, studies have focused on areas of enquiry that may lead to "functional" progesterone withdrawal, such as the role of prostaglandin receptors ([@B110]; [@B120]) and the minutiae of inflammation control by cytokine cascades and specific transcription factors ([@B76]; [@B122]). Understating the trigger for labor onset is important for us to decipher how this may deviate in patients with PTB. It is also important to know how this labor mechanism interfaces with the trigger for the initiation of fetal membrane remodeling and weakening, another pathway that is poorly understood.

The idea that cellular stress is the trigger for both fetal membrane weakening, and labor, has been gaining traction ([@B96]). Suggested stressors for this mechanism have included; stretch/distension ([Figure 1](#F1){ref-type="fig"}) of fetal membranes ([@B104]; [@B61]) and myometrium ([@B170]), and also general hypoxia/oxidative stress in all of the tissues of pregnancy. Both of these stressors are known to increase in the human fetal membranes with gestational age or labor ([@B24]; [@B61]), and also to stimulate inflammation ([@B69]; [@B99]). This has been demonstrated in all of the tissues of pregnancy and pregnancy complications result from the altered levels of cell stress in these tissues ([@B32]). Indeed, several studies have shown that oxidative stress is linked to cell aging and senescence in cells of the amnion, directly leading to increased inflammation ([@B98]; [@B94]). It has also been shown to lead to epithelial to mesenchymal transition in the amnion, which can also play a role in the maintenance of the integrity of this tissue ([@B135]). Other distinct types of cellular stress that have also been the subject of study in the human fetal membranes, including, Endoplasmic Reticulum Stress ([@B83]) and Mitochondrial Stress ([@B163]). In addition, cells can also respond to stress in a variety of way such as initiating, the heat shock response, the unfolding protein response or a DNA damage response ([@B40]). Therefore, there are many specific pathways and mechanisms that constitute the wide umbrella term "cell stress," these should be further investigated to elucidate their contribution to the inflammation and cellular responses seen as the fetal membranes weaken.

![The cellular structure of the fetal membranes and their biophysical forces. The human fetal membranes consist of a multi-layered structure which surround the fetus in utero. It is composed of the amnion, chorion and decidua (upper box). Biophysical forces are placed on these fetal membranes (lower box depicted looking down onto the apical surface of the amnion epithelium). **(A)** Linear physical forces due to multi-directional stretching of the fetal membranes adherent to the decidua. **(B)** Dynamic physical forces on the fetal membranes due to fetal movements, Braxton Hicks contractions and eventually labor. (This Figure was created using BioRender).](fphys-11-00602-g001){#F1}

One of the ways in which cell stress may lead to inflammation is through the production of Danger Associated Molecular Patters (DAMPs), also known as Alarmins ([@B145]). These molecules typically have a different specific function during normal cellular activity, but when the cell detects a stress stimulus, they are activated now functioning to signal "the alarm.". Many different molecules are classified as DAMPs, including various heat shock proteins (HSP), extracellular matrix (ECM) breakdown products, and nucleic acid fragments ([Table 1](#T1){ref-type="table"}; [@B120]). DAMPs are already known to have a role in a wide range of other diseases with strong inflammatory signatures, such as, autoimmune diseases (Systemic Lupus Erythematosus, Rheumatoid Arthritis), Osteoarthritis, cardiovascular diseases, neurodegenerative diseases and cancer ([@B137]). Here, they perpetuate a positive-feedback cycle of cellular damage, inflammation and then more cellular damage ([@B137]). DAMPs are known to activate various Pattern Recognition Receptors (PRRs), including the Toll-like receptor (TLRs) family ([@B157]; [@B66]) and through these receptors, they can cause the activation of the pro-inflammatory transcription factor Nuclear Factor Kappa-B (NF-κB), changes in the levels of Matrix Metalloproteinases (MMP) and stimulate apoptosis ([@B137]). Due to the large number of wide-ranging biomolecules acting as DAMPs ([Table 1](#T1){ref-type="table"}) and the large number of different receptors involved, they produce their effects by working through a complex number of distinct signaling pathways.

###### 

Summary of key Danger Associated Molecular Patterns, their receptors and mechanisms.

  Origin                 DAMP                         Receptor           Function (standard font = pro-inflammatory; italics = anti-inflammatory)                                                                                                                                     References
  ---------------------- ---------------------------- ------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------
  Extracellular Matrix   Aggrecan 32 mer fragment     TLR2               (iNOS), CCL2, IL-1α, IL-6, MMP12 MMP13 and ADAMTS5                                                                                                                                                           [@B152]
                         Biglycan                     TLR2/4             Increases levels of reactive oxygen species, CXCL-1, CCL2 and HSP70, and activates NLRP3 inflammasome by Caspase-1 and the maturation of IL-1β *Activating a TLR co-adaptor that activates IFN1 signaling*   [@B39]; [@B142]; [@B136]
                         Decorin                      TLR2/4             Decreases TGFβ1 and IL-10 and increases levels of apoptosis                                                                                                                                                  [@B100]
                         **\***Fibronectin            TLR2/4             Promotes pro-inflammatory mediators and phagocytosis by macrophages                                                                                                                                          [@B50]; [@B35]
                         Fibrinogen                   TLR4               Activation of monocytes                                                                                                                                                                                      [@B4]
                         LMW-HA                       TLR2/4             Activates NLRP3 inflammasome by Caspase-1 and the maturation of IL-1β. Activates NF-kB                                                                                                                       [@B100]
                         HMW-HA                       TLR2               *Activates a TLR co-adaptor that activates IFN1 signaling*                                                                                                                                                   [@B144]; [@B39]
                         Heparin sulfate              TLR4, RAGE         Activation of NF-kB                                                                                                                                                                                          [@B180]
                         Tenascin C                   TLR4               Synthesis of pro-inflammatory cytokines                                                                                                                                                                      [@B103]
                         Versican                     TLR2/4 CD14        IL-6, IL-1β, Il-12 and CCL2 production *Increasing IL-6 (anti-inflammatory pathways), IL-10*                                                                                                                 [@B177]
  Cytosolic              ATP                          P2XR P2YR          Attracts macrophages by inflammasome activation MAPK wound healing response                                                                                                                                  [@B168]
                         Cyclophilin                  CD 147             Chemotaxis and the production of pro-inflammatory factors                                                                                                                                                    [@B21]
                         F-actin                      DNGR1              DNGR1 recognizes the released F-actin, which causes the uptake of damaged or dead cells                                                                                                                      [@B19]
                         Heat Shock Protein           TLR2/4             MyD88 dependent activation of NF-kB                                                                                                                                                                          [@B166]; [@B133]
                         S100 proteins                TLR4, CD147 RAGE   Leads to apoptosis and activates ERK and NF-kB or AP1                                                                                                                                                        [@B43]; [@B179]
                         **\***Soluble amyloid beta   TLR2/4             Enhanced TNF driven inflammation                                                                                                                                                                             [@B174]
                         Uric Acid                    NLRP3              Inflammasome activation and induction of IL-1β maturation                                                                                                                                                    [@B16]
  Mitochondrial          mtDNA                        TLR9               p38 MAPK and NF-kB activation                                                                                                                                                                                [@B184]; [@B183]; [@B86]; [@B9]
  Nuclear                **\***Cell free DNA          TLR9               Activation of NF-kB and AP1                                                                                                                                                                                  [@B86]
                         Circulating Histones         TLR9               Inflammation through the activation of NF-kB                                                                                                                                                                 [@B57]; [@B65]
                         Extracellular self RNA       TLR7 TLR3          Sensitizes other TLR working synergistically with their other ligands MAPK, NF-κB, and IRF-5/7 pathways through MyD88 signaling                                                                              [@B63]; [@B22]; [@B165]; [@B114]; [@B124]
                         **\***HMGB1                  TLR2 TLR4 TLR9     Activation of NF-kB, and MAPK signaling though ERK and p38, release of MMPs                                                                                                                                  [@B130]; [@B112]
                                                                                                                                                                                                                                                                                      [@B97]; [@B18]; [@B127]
                         IL-1α                        IL-1R              MAPK signaling and NF-kB activation                                                                                                                                                                          [@B13]
                         IL-33                        ST2                NF-kB activation and TNF production                                                                                                                                                                          [@B59]
                         SAP130                       Mincle             Triggering pro-inflammatory cytokine secretion                                                                                                                                                               [@B185]; [@B121]

\* denotes has been studied in the fetal membranes or cells of the fetal membranes. ADAMTS5, ADAM metallopeptidase with Thrombospondin type 1 motif 5; AP-1, Activator protein 1; CD, Cluster Differentiation; DNGR1, Dendritic cell natural killer lectin group receptor-1; ERK, extracellular-signal-regulated kinase; HSP, Heat Shock protein; IFN1, Interferon; IL, Interleukin; iNOS, Inducible Nitric Oxide; IRF, Interferon regulatory factors; MMP, Matrix Metalloproteinase; MyD88, myeloid differentiation primary response protein 88; NF-kB, Nuclear Factor Kappa B; NLRP3, LRR- and pyrin domain-containing protein 3; RAGE, advanced glycation end products; ST2, suppression of tumorigenicity 2; TGF, Transforming growth factor; TLR, Toll-like receptor; TNF, Tumor Necrosis Factor.

The Weakening and Subsequent Rupture of the Human Fetal Membranes Is Dependent on Biophysical and Biochemical Change {#S3}
====================================================================================================================

The fetal membranes are a multilayered structure composed of various cell types and associated ECM ([Figure 1](#F1){ref-type="fig"}). The normal rupture of these membranes is currently thought to be the result of both physical forces and biochemical changes. The physical properties of fetal membrane strength are known to originate from the layer closest to the fluid and fetus ([Figure 1](#F1){ref-type="fig"}), the amnion ([@B6]). The strength of this tissue is undoubtedly derived from the combination of its layers working in concert. Some of this may come from the interface between the amnion and chorion. This region in the amnion is described as a spongy layer that is ECM rich ([Figure 1](#F1){ref-type="fig"}), consisting of proteoglycans, glycoproteins and type III collagen ([@B153]). The interface between this and the chorion consists of a gelatinous substance made up of hyaluronan, decorin, buglycan and collagen that mediates the separation of the amnion and chorion prior to fetal membrane rupture ([@B92], [@B93]). This separation is the first step in the weakening of the fetal membranes ([@B6]). The chorion adheres to the decidua between weeks 14 and 16 of pregnancy, by the degeneration of the capsular decidua and fusion of the chorion with the parietal decidua ([@B42]). Thus, this integration with the maternal tissues may also provide some strength to the tissue. However, the fetal membranes typically rupture in the region that is above the cervix ([@B87]; [@B153]). *In vitro* it has been shown that after its separation from the amnion, this chorion layer is next to rupture ([@B6]). Therefore, as the amnion layer is last to rupture in this sequence, after a notable period of deformation, it is widely accepted that the ECM rich compact layer containing amnion mesenchymal cells (AMC) ([Figure 1](#F1){ref-type="fig"}) accounts for the strength and maintains the integrity of this tissue ([@B6]).

An increase in apoptosis ([@B37]; [@B56]; [@B73]) and changes in the levels of MMPs ([@B30]) are central to the biochemical component of the changes that occur in the fetal membranes before their rupture. Although cell death in the form of apoptosis is recognized as important for the weakening process, it is thought that these cells can also die through autophagy ([@B146]; [@B102]) and perhaps necrosis ([@B99]), as both of these forms of cell death are also known to be the result of cell stress ([@B40]). In addition, it is known that necrosis can occur as the result of TLR activation in other cells ([@B101]). Although cellular survival is obviously directly linked to the maintenance of the integrity of the amnion, its physical strength is dependent on the synthesis and degradation of the components of the ECM ([@B34]; [@B5]) controlled by resident cells ([@B119]). Indeed, women with connective tissue disorders and related diseases are at an increased risk for complications during pregnancy, including pPROM ([@B5]). Support for this mechanism has come from several research groups as they have biochemically and mechanically identified a "zone of altered morphology" (ZAM) in the human fetal membranes ([@B91]; [@B34]; [@B117]; [@B134]). The ZAM constitutes a discrete zone of weakness overlying the cervix characterized by several features; an increased thickness and swelling of the connective tissue layer, a reduction in both the cytotrophoblast and decidual layers, and a reduced overall thickness of the supracervical membranes that exhibits increased ECM remodeling ([@B76]), and apoptosis ([@B146]). It is also known that inflammation in the form of increased cytokine secretion and signaling are also involved in the initiation and progression of membrane rupture both at term and preterm. This is particularly evident when associated with intrauterine infection and chorioamnionitis ([@B15]). However, it is important to note that inflammation in the absence of infection, in the form of what has been coined "sterile inflammation," leads to pPROM and normal rupture of the membranes ([@B147]). Roles for several key pro-inflammatory cytokines; Interleukin 1β (IL-1β), IL-6, IL-8, and Tumor Necrosis Factor-α (TNF-α) in parturition are apparent. Their increase in abundance in gestationally advanced fetal membranes is not only associated with labor ([@B67]) but they have also all been demonstrated to independently increase the synthesis of MMPs ([@B15]). Additionally, many of these cytokines can cause the translocation of the pro-inflammatory transcription factor NF-κB thus leading to further increases in inflammatory mediators. This provides a pathway of pro-inflammatory self-induction ([@B29]) that is thought to terminate with delivery of the fetus. This can be exemplified by the chemokine IL-8, which leads to the increased infiltration of polymorphonuclear leukocytes, which can further contribute to the increase in inflammation in a feed-forward manner and can lead to birth. In further support of a central role for cytokine-induced cascades in membrane weakening, TNF-α and IL-1β have been shown to directly cause significant weakening of fetal membranes, inducing the biochemical markers characteristic of the ZAM ([@B74]).

In addition to the polymorphonuclear leukocytes that are attracted to the tissue by chemokines, an infectious inflammatory response leads also leads to the recruitment of macrophages. These produce cytokines, MMPs, and prostaglandins, which increase the risk of pPROM ([@B119]). In addition, stimulated monocytes in human chorionic cells produce the inflammatory cytokines IL-1α and TNFα, which result in the increased expression of MMP-1 and MMP-3 ([@B64]; [@B150]). In fetal membranes with chorioamionitis, adhesive granulocytes have also been noted adjacent to apoptotic amnion epithelial cells (AECs) near the rupture site ([@B77]). Together these data illustrate how immune cells promote cellular changes within the fetal membranes by driving inflammation, and breaking down ECM through the production of MMPs, predisposing the tissue for rupture. However, more recently it has been demonstrated that immune cells may also have fetal membrane healing properties through the migration of macrophages from the amniotic fluid to a rupture site in the amnion ([@B107]). These cells were seen to induce wound healing by secreting IL-1β and TNFα and stimulating epithelial to mesenchymal transition ([@B107]).

It is thought that the forces produced by the cell stressor distension, may be the link between the biochemical and biophysical changes seen in the fetal membranes toward term. This was originally based on the observation that human pregnancies with more than one fetus often result in premature delivery ([@B68]). The insertion and subsequent slow inflation of a balloon above the cervix in humans is also known to induce labor ([@B88]). This led to the study of the distension of the uterus to discern the resultant biochemical changes and how they might lead to the activation of uterine contraction ([@B148]). Less work has been performed studying the effect of distension on the fetal membranes although it has been clearly shown that they are massively stretched *in vivo* at term ([@B104]; [@B61]). It is assumed that this is the result of the combination of their adherence to the uterine wall and the termination of cellular proliferation, halting their further growth, at the beginning of the third trimester ([Figure 1](#F1){ref-type="fig"}). Work performed stretching both the uterus, pieces of fetal membranes ([@B111]) or cells of the amnion ([@B70], [@B71]) show that this stimulus is able to induce pro-inflammatory cytokine production and secretion, and can also regulate apoptosis ([@B70]; [@B129]). Thus, the distension of the fetal membranes in normal term pregnancies and its over distension in PTB, can lead to its inflammatory signature. This distension also constitutes a significant source of cellular stress through physical strain. Interestingly, our recently collected data confirms that cellular distension of cells of the amnion *in vitro* can indeed act as a cell stressor, increasing the secretion of the DAMP, High mobility group box 1 (HMGB1) ([@B115]).

Danger Associated Molecular Patterns Are a Large Group of Biomolecules With Distinct Cellular Compartmentalization {#S4}
==================================================================================================================

Danger Associated Molecular Patterns are a wide-ranging group of biomolecules, originating from various cellular compartments. These molecules were classified as DAMPs when released, activated or secreted in response to tissue injury, and by damaged or dying cells ([@B142]). They can originate from nuclear or intracellular location, or cleaved from ECM. They have a wide range of effects resultant from their interaction with PRR on both immune cells and endogenous cells of organs ([Table 1](#T1){ref-type="table"}). The intention here is not to discuss an exhaustive list of all those that have been identified to date, but to briefly highlight the distinct origins of DAMPs and discuss what is known about them in the fetal membranes ([Table 1](#T1){ref-type="table"}).

The ECM has an important role in shaping the innate immune response, it is dynamic, not simply a static network that provides tissue integrity and strength. The majority of DAMPs coming from the ECM are derived from proteoglycan or glycoprotein ([Table 1](#T1){ref-type="table"}), and are typically released by the cleavage by MMPs, Hyaluronidase, and Heparanase ([@B41]). However, they can also be *de novo* synthesized or released by unfolding due to mechanical stimulation ([@B149]). When released, they function to trigger sterile inflammation or prolong pathogen-induced responses by "fine-tuning" the production of inflammatory mediators ([@B38]). Some are known to promote inflammation, whereas others are also anti-inflammatory ([@B38]). These diverging roles are dependent on the activation of specific signaling profiles working through specific PRRs. Thus, these DAMPs work to modulate inflammation by their interaction with a range of receptors including; TLRs (TLR2 and TLR4), RIG-1-like receptors (RLRs), NOD-like receptors (NLRs), receptor for advanced glycation end products (RAGE), integrins and cluster differentiation 44 (CD44). Although their role has not been directly studied in the fetal membranes, it is reasonable, given that the amnion that provides the strength of the tissue is ECM rich ([Figure 1](#F1){ref-type="fig"}) and is subject to cell stress in the form of distension toward term, that these molecules could have a key role in driving the weakening mechanisms of this tissue toward the end of gestation.

A wide range of DAMPs from various intracellular origins have also been characterized ([Table 1](#T1){ref-type="table"}). They can be cytosolic, endoplasmic, or they can also be released from granules or the plasma membrane. However, one of the most important unifying characteristics of this group of DAMPs is that when "activated" by cell stress, they typically change cellular compartment and lead to differential signaling events, compared to those seen during their normal biological role in "unstressed" conditions. In addition, various proteins and nucleic acids from the nucleus and mitochondria have been widely studied for their DAMP roles ([Table 1](#T1){ref-type="table"}). This group of DAMPs include but are not limited to; HMGB1, circulating histones, various interleukins, Free DNA, mitochondrial DNA, and self-extracellular RNA. The variety of DAMPs provide a range of receptor specificity and pro/anti-inflammatory functionality ([Table 1](#T1){ref-type="table"}).

Danger Associated Molecular Patterns and Pathogen Associated Molecular Patterns Activate Pattern Recognition Receptors {#S5}
======================================================================================================================

It is clear that DAMPs cause inflammation in other tissues, therefore we believe they could be the key regulators that begin the weakening of the fetal membranes by driving inflammation during this process too. They elicit their effects through numerous receptors known as PRRs. One of the largest groups of receptors that belong to this group is the TLRs. They are a distinct class of germline-encoded PPRs that initiate the innate immune response for the initial detection of a pathogen ([@B176]). They are located on cell surfaces or within endosomes and generally have a conserved function to protect against pathogens via activation of downstream signaling pathways ([@B66]). Several roles of TLRs have been identified including the clearance of pathogenic microbes, protection of endogenous threats, and regulation of the innate and adaptive immune response ([@B58]). There are ten TLR isoforms (TLR1--10) in humans that are expressed on immune and non-immune cells including macrophages, fibroblasts, epithelial cells, and endothelial cells ([@B75]). TLR1, TLR2, TLR4, TLR5, and TLR6 are expressed on the cell surface, whereas TLR3, TLR7, TLR8, and TLR9 are expressed in endosomes ([@B156]; [@B75]). TLR10 is a distinct receptor, in that it is the only TLR known to act as inhibitory protein through the induction of anti-inflammatory cytokine IL-1Ra ([@B116]).

The cell surface TLRs mainly recognize PAMPs generated from cell wall components and flagellin from gram positive and gram-negative bacteria, yeast, and fungi ([@B25]). Interestingly, the recognition of DAMPs by these cell surface TLRs are shown to require different co-receptors and accessory molecules to the PAMPs. The endogenous ligands of these receptors appear to be limited, perhaps to help constrain TLR responses so that they can sufficiently function for pathogenic recognition, without causing detrimental responses to the host ([@B105]). The intracellular TLRs (TLR3, 7, 8, 9) function within endolysosomal compartments and detect foreign nucleic acids that are signatures often belonging to invading viruses and microbes ([@B14]). Generally, it is thought that the endosomal TLRs are able to distinguish between host and foreign nucleic acids, although there is mounting evidence that some TLRs may not have this ability, and cannot discriminate between the nucleic acid molecules of host and microbial origin ([@B14]). It is known that endogenous mRNA and RNA from necrotic cells can also activate the intracellular TLR mediated pathway ([@B63]; [@B22]; [@B165]), resulting in an antiviral and pro-inflammatory response via Interferon (IFN) and cytokine induction ([@B123]).

Although the family of TLRs were originally identified for their abilities to recognize and mediate signaling pathways for a variety of microbial components ([@B128]; [@B159], [@B160], [@B161]; [@B53]; [@B3]; [@B52]; [@B85]) many studies have shown that they are important in the detection of endogenous DAMP molecules ([Table 1](#T1){ref-type="table"}; [@B12]; [@B171]). This is where the function of PAMPs and DAMPs differ, as DAMPs are also necessary for tissue repair. Further exploration into the exogenous (PAMP) and endogenous (DAMP) ligand activation of the TLR family may provide new and effective therapies to mediate the negative effects of TLR-driven inflammation.

Several PRRs and co-receptors other than the family of TLR have also been shown to be important for the function of DAMPs and PAMPs ([@B158]). These include, but are not limited to, RLRs, NLRs, RAGE, C-type lectin receptors (CLRs), P2X purinoceptor 7 receptors (P2X7Rs), LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome, and distinct members of the cluster differentiation receptor family. Similarly, to TLRs, all of these receptors are responsible for triggering distinct inflammatory cascades of the immune response. Some literature suggests that the intervention of DAMP and PAMP driven inflammation through these receptors, and their specific signaling signatures, may ablate the negative effects of associated pathologies ([Figure 2](#F2){ref-type="fig"}).

![DAMP/PAMP PPR pathway manipulation. **(A)** TLR, Mincle, and P2X7 receptor activation regulated by DAMP and PAMP signaling have been shown to stimulate downstream pathways involving various modulatory proteins (ERK, GSK3B, GIT2, SYK). This may activate AP-1, NFkB, IRF1/5, or inflammasome activation that leads to induction of pro-inflammatory cytokines. Studies have demonstrated different areas of modulation (1--8) that can manipulate DAMP/PAMP mediated inflammation associated with PTB. **(B)** The supporting table lists several interventions that demonstrate the manipulation of the DAMP/PAMP mediated pathways that correspond to the different areas of modulation.](fphys-11-00602-g002){#F2}

Danger Associated Molecular Patterns and Pattern Associated Molecular Patterns in the Fetal Membranes {#S6}
=====================================================================================================

There is a growing body of evidence demonstrating that DAMPs and PAMPs work via a similar set of PRRs to guide the responses of innate immune system. However, much of what we understand about the potential of DAMPs to cause fetal membrane weakening and pPROM comes from work studying the effect of PAMPs in this and other tissues. However, it cannot be assumed that the signaling events and downstream outcomes between these two groups of biomolecules (DAMPs and PAMPs), are identical, even during their activation of the same receptor. Regardless, work on the role of PAMPs in the fetal membranes has been able to provide us with insights as to how DAMPs may also function, providing foundational data that can guide our understanding of their potential as directors of fetal membrane weakening. There is a clear link between fetal membrane weakening and PAMP driven inflammation in PTB with pPROM. Indeed, TLR-mediated PTB in response to PAMPs have been studied and extensively reviewed elsewhere ([@B164]). Thus, the intention of this review is to discuss the work most relevant to and that was performed in the fetal membranes.

PAMP Activation of Inflammation in the Fetal Membranes {#S6.SS1}
------------------------------------------------------

Inflammation initiated by bacterial infection causes PTB by preterm labor and pPROM. The initiation of this inflammation is caused by different PAMPs upon their interaction with their specific TLR; for example, lipopolysaccharide (LPS) with TLR4. To determine the role of PAMP ligands specifically in fetal membranes, numerous *ex-vivo* tissue explant studies have been completed. Under normal physiological conditions the fetal membranes express all of the TLR isoforms (1-10) that could be activated and lead to specific pro-inflammatory signatures. Indeed, the treatment of fetal membrane explants with bacterial TLR agonists; peptidoglycan (TLR2), LPS (TLR4), and flagellin (TLR5) all produce a pro-inflammatory response with increased production of various cytokines, including; IL-1β, IL-6, IL-8, IL-10, granulocyte colony stimulating factor (G-CSF), macrophage inflammatory protein (MIP-1A) and Regulated upon Activation Normal T Expressed and Secreted (RANTES) ([@B55]).

Not only do bacterial ligands lead to infection driven inflammation but they also lead to increases in the receptors that detect them. This was demonstrated in normal human fetal membranes, where the levels of TLR expression changed upon exposure to various bacteria associated with PTB pPROM. Specifically, treatment with the bacterial stimuli *Mycoplasma hominis* lead to increased expression of TLR 4, 6, and 8. Increased expression of TLR8 was also seen with *Ureaplasma parvum* and increased expression of TLR7 upon treatment with *Porphyromonas gingivalis*. Interestingly, gram negative *E. Coli* significantly decreased TLR10 expression rather than increase TLR expression as demonstrated by the other bacterial stimuli. This is of note as TLR10 is still considered an orphan receptor and therefore its function is not well understood. These data suggest that fetal membranes vary their TLR expression levels upon treatment with bacterial ligands. This observation may be used in the future to indicate the severity of infection and differences in the receptor expression level will likely further direct the magnitude of an inflammatory immune response ([@B1]). In further support of the bacterial ligands affecting the levels of the TLRs, fetal membranes with chorioamnionitis, have also been shown to have differential expression of TLRs. The increased expression of *TLR1* at the gene level in preterm fetal membranes with histological chorioamnionitis has been described ([@B175]), as have increases in TLR1, TLR2, TLR4, and TLR6 in chorioamniotic fetal membranes ([@B106]). Together these data suggest a role for these receptors not only in the surveillance of bacteria in this tissue but also that they adapt to the bacterial challenge.

Chorioamnionitis is not the only route to bacterial infection in the fetal membranes. Periodontal disease is a chronic inflammatory disease caused by multiple strains of bacteria, several of which have been detected in amniotic fluid, placenta and fetal membranes. It is now accepted that there is a link between these bacterial and several pregnancy complications including PTB. *P. gingivalis* has been detected in chorionic tissue and LPS derived from it, used to treat chorion derived cells. This resulted in increased expression of TLR2 causing the increased production of IL-6 and IL-8. To further study this relationship, TLR-2 gene-silenced chorionic derived cells demonstrated a reduction in IL-6 and IL-8 secretion. Taken together this suggests an important role for TLR2 in periodontic bacterial signaling in the fetal membranes ([@B51]). In support of this, the periodontal bacteria *Fusobacterium nucleatum* has also been detected in chorionic tissue from high-risk pregnant women. Similarly, to the previous study, it was then used to treat chorionic cells where it was also able to increase inflammation by increasing IL-6 and corticotrophin-releasing hormone (CRH) secretion via TLR2 and TLR4 activation ([@B162]). These data indicate that periodontal bacteria act similarly to other PAMPs in these tissues as they find their way into the amniotic fluid, placenta and fetal membranes, where they activate the TLR system and downstream inflammation.

Although humans are not thought to experience the sharp drop in progesterone that is thought to initiate the onset of parturition in other animals ([@B95]), its administration is used to maintain pregnancy and lower the risk of PTB ([@B26]) as it is thought that humans may experience a "functional" progesterone withdrawal ([@B110]). Progesterone (P4) has been shown to have a protective role in fetal membranes by reducing pro-inflammatory cytokine production upon LPS treatment ([@B36]). It does this in part by significantly reducing TLR4 expression upon LPS treatment. This directly results in the reduced secretion of the pro-inflammatory cytokines TNFα, IL-6, and β-defensin 2 (HBD2) ([@B36]). Therefore, this intriguing mechanism could be a way for progesterone to decrease the ability of this tissue to detect DAMPs until its functional levels decrease toward the end of gestation.

Animal models have also been used to determine how PAMPs induce inflammation leading to different pregnancy complications. They have also provided models of PTB that can be used to test novel therapeutic targets. In humans, the histological assessment of preterm fetal membranes detected TLR4 expression in the fundus and low segment suggesting a role in PTB ([@B28]). This receptor's role was further investigated in an infection, LPS-induced PTB mouse model. The TLR4 antagonist (+)-naloxone, was able to suppress the expression the inflammatory cytokines IL-1β, IL-6, TNFα, and IL-10 and prevent PTB. Another study also established the role for TLR4 in PTB by using a mouse model by inducing infection with an LPS variant, heat killed *E. Coli* (HKE). HKE treatment induced PTB in all TLR4 normal mice compared to none of the TLR4 mutant mice. In addition, another study induced PTB in CD1 mice by administering intrauterine injections of saline, peptidoglycan (PGN, TLR2 agonist) or polyinosinic-polycytidylic acid (Poly I:C, TLR3 agonist) ([@B60]). The regulation of a2 isoform of V-ATPase (a2V) has a role in pregnancy and was assessed post exposure to these two ligands, PGN and Poly I:C. This led to significantly decreased expression of a2V in the fetal membranes and play a role in the induction of PTB in mice ([@B60]).

Collectively, several mouse studies have provided evidence that demonstrate the importance of bacterial PAMP/TLR driven inflammation to cause PTB. Providing model systems that can be continued to be used to study future therapies to address PTB by these pathways. Indeed, models activating TLRs by ligand injection ([@B62]; [@B172]) or placental stimulation ([@B84]; [@B72]) are also models for PTB.

PAMP Stimulation of Amnion Epithelial Cells Isolated From Fetal Membranes {#S6.SS2}
-------------------------------------------------------------------------

Human AECs form the most superficial layer of the fetal membranes functioning as an immunological barrier for the fetus against intra-amniotic infection. Their response to pregnancy specific PAMP ligands has been studied to help us understand the contribution of these cells to inflammation in the fetal membranes but also to their production of pro-inflammatory signaling molecules that may also communicate with the growing fetus. Under normal physiological conditions, these cells express TLR 1-10 and can be activated by the PAMPs that reach them. TLR5 and TLR 2/6 activation by PAMP the ligands, Flagellin and macrophage-activating lipopeptide-2 (MALP-2), respectively, significantly increase the secretion of IL-6 and IL-8 ([@B44]). They also cause the nuclear translocation of NF-κB subunit p65, thus inducing a pro-inflammatory response. The activation of TLR4 by LPS, however, has also been demonstrated to induce apoptosis and decrease cell viability of these cells ([@B44]). However, the activation of this receptor also increases Transforming Growth factor beta 1 (TGFβ1) and prostaglandin E2 (PGE2), TNFα and IL-1β production ([@B108]), which has been confirmed for TGFβ1 and PGE2 but not for IL-1β, IL-6, and IL-10 ([@B155]). Taken together these data suggest that not only does the activation of this PAMP TLR mechanism mediate an immunological response to PAMPs in AEC, but it could contribute to the inflammation seen in the fetal membranes with PTB and may also signal to the fetus when an infection was detected. It is possible that AMC respond similarly to AEC to PAMP stimulation, however, there has been a lack of focus on this system in AMC. In addition, differences in the fundamental functions of these cells in the fetal membranes make it difficult to evaluate similarities between them. Thus, it is challenging to know how similar the pathway signaling is in this cell type, that functions to maintain the integrity of ECM in the fetal membranes.

PAMP Stimulation of Amnion Mesenchymal Cells Isolated From Fetal Membranes {#S6.SS3}
--------------------------------------------------------------------------

Human AMCs are located within the ECM rich layer of the amnion that is closest to the chorion in the of fetal membranes ([Figure 1](#F1){ref-type="fig"}). This layer is responsible for the maintenance of the strength and integrity of the whole tissue. Our work has shown that the human AMCs isolated from human fetal membranes express all ten TLR isoforms ([@B140]). This suggests that similarly to AECs, AMC are able to detect PAMPs and produce a pro-inflammatory signature. However, as their location and function are different to that of AEC, the downstream consequences may also be different. We have also been able to show that indeed the TLR2/6 ligand MALP-2, could increase the pro-inflammatory cytokines and NF-κB translocation, it did not increase levels of apoptosis.

Viral PAMP Activation of the Fetal Membranes {#S6.SS4}
--------------------------------------------

In addition to bacterially derived PAMPs, viral infection also elicits an immune response through the activation of TLRs. This is typically through the release and subsequent detection of viral nucleic acids. TLR 3, 7, 8, and 9 are all nucleic acid ligand response receptors that are activated upon exposure to viral nucleic acid ligands. Thus, fetal membrane explants treated with viral double stranded RNA (dsRNA) and viral single stranded RNA (ssRNA) activate TLR 3 and TLR8, respectively, and induce downstream pro-inflammatory cytokine production that result in two different distinct antiviral response profiles ([@B8]). Those explants treated with Poly (I:C) (TLR3), or the viral ligands, imiquimod (TLR7), and ssRNA40 (TLR8) also caused the production of pro-inflammatory cytokines IL-6 and IL-8 ([@B20]). Although there is little data on the response of the fetal membranes to viral PAMPs, these data support the idea that all of the viral, as well as bacterial TLR receptors are able to be activated on cells of the fetal membranes and that they could result in inflammation, potentially leading to fetal membrane weakening and rupture.

DAMPS and Fetal Membranes {#S6.SS5}
-------------------------

Work studying the direct effect of DAMPs or DAMP production by the fetal membranes is limited. Indeed, so far to our knowledge only four have been directly tested in the fetal membranes ([Table 1](#T1){ref-type="table"}). However, others that have also been shown to play a role in pregnancy are, HMGB1, cell-free fetal DNA (cffDNA), uric acid and IL-1. Little is known about the specific roles of any of these molecules in fetal membranes, and their potential as novel therapeutic targets and biomarkers in the pathologies of pregnancy.

High mobility group box 1 is the most comprehensively studied DAMP in the fetal membranes and has been shown to be a critical regulator throughout different stages of pregnancy. It activates TLRs to initiate an inflammatory immune response in a sterile environment, but it is also released by PAMP stimulation of TLRs. This was confirmed by its presence in the Amniotic fluid from preterm mothers with damaged fetal membranes due to intra-amniotic infection ([@B10]). Its increase in levels also correlate with increases in IL-6 and with infection in amniotic fluid but its does not seem to increase with gestational age in this compartment. HMGB1 levels are also elevated in chorioamniotic membrane extracts from preterm labor compared to term labor ([@B127]) and it has been seen that this increase contributes to increased expression of pro-inflammatory cytokines ([@B127]). It also increases *MMP-9* gene expression and active-MMP-9 levels in chorioamniotic fetal membrane explants, compared to control treated fetal membranes ([@B127]). These data suggest that HMGB1 induction of MMP-9 could directly promote fetal membrane weakening. Pregnant mice treated with intra-amniotic injections of HMGB1 resulted in increased pup mortality, PTL and PTB compared to pregnant mice treated with PBS ([@B47]). This study did not asses the role of HMGB1 in the fetal membranes, but these data suggest HMGB1 has an important role in promoting PTB. Fetal membranes treated with exogenous HMGB1 increase TLR2 and TLR4 expression and activation of the inflammatory immune response regulator, p38 Mitogen Activated Protein Kinases (MAPK) which also leads to a senescent phenotype consistent with a sterile inflammatory response ([@B18]). Moreover, term fetal membranes have a phenotype consistent with senescent cells, reduced telomeres, increased activation of p38 MAPK and increased in senescence-associated beta (SA-B) galactosidase and senescence-associated secretory phenotype (SASP) gene expression found a senescent phenotype ([@B96]). HMGB1, oxidative stress and apoptosis is also increased in normal fetal membrane explants exposed to cigarette smoke extract compared to control treated fetal membrane explants ([@B97]). In a study that also linked HMGB1 with fetal membrane weakening, fetal membranes from women who had preterm labor or pPROM were found to have increased levels of HMGB1 in their serum ([@B131]). This suggests that HMGB1 could also be a potential biomarker for PTB. Immunofluorescent labeling of fetal membranes delivered preterm with chorioamnionitis also showed HMGB1 localized AECs, with more diffuse labeling in the myofibroblast and macrophages compared to term fetal membranes delivered at term ([@B138]). Interestingly, another study has demonstrated that microRNA 548 (miRNA) regulates the expression of HMGB1 in fetal membrane tissues with very minimal expression in preterm chorioamniotic fetal membranes ([@B151]). Induced expression of miRNA 548 in isolated epithelial cells from fetal membranes decreased HMGB1 levels and pro-inflammatory cytokine levels. Together these data strongly suggest that although HMGB1 secretion is increased during the cellular stress of infection it may also have a role in a sterile immune response working in autocrine and paracrine ways that could contribute to PTB.

A possible role for serum amyloid A1 (SAA1) in ECM remodeling was assessed in amnion fetal membrane explants. Human amnion fetal membrane explants treated with SAA1 showed increased protein expression of MMP-1, MMP-8, and MMP-13 compared to control treatment ([@B174]). The increased expression of MMPs suggest a potential role for SAA1 in ECM remodeling in fetal membranes after rupture.

TLR9 recognizes unmethylated CpG-containing DNA sequences in addition to bacterial and viral DNA to activate an immune response, similarly to all the other DAMPs. cffDNA is one of the few nucleic acid DAMPs that have been studied in the context of a placental source of cffDNA. It is thought that cffDNA released from the placenta can circulate in the maternal plasma to activate TLR9 on leukocytes and macrophages. This then can induce a pro-inflammatory immune response that triggers labor, which ultimately leads to birth ([@B125]). A study in support of the importance of this group of DAMPs, demonstrated that TLR9 is expressed on fetal membranes from term placentas in the presence and absence of labor ([@B11]). Indeed, its levels are highly expressed in AEC ([@B44]; [@B140]) and AMC ([@B140]). Exosomes from senescent AECs are known to package cffDNA and HMGB1 that could also to signal within the fetal membranes acting as a trigger for parturition ([@B145]). In further support of this, human peripheral blood mononuclear cells (PBMCs) treated with fetal DNA or CpG DNA increased IL-6 secretion and pregnant Bagg Albino (BALB/c) mice injected with fetal DNA, CpG DNA or LPS increased the number of resorbed fetuses. In addition, TLR9 knockout mice treated with fetal DNA showed decreased numbers of resorbed mice, whereas those treated with the TLR9 inhibitor Chloroquine reduced fetal resorptions and IL-6 production. This suggests a role for TLR9 in promoting PTB upon cffDNA treatment ([@B143]). More studies are needed to show the mechanism by which cffDNA could contribute to the activation of parturition and also what role it has in the fetal membranes where the expression of its detection receptors is high in AEC and AMC ([@B140]).

To our knowledge only one study has specifically tested the activation of AMC by DAMPs. In this study the authors elegantly show that the TLR4 receptor is present and able to be activated by the DAMP, fetal fibronectin, on AMC ([@B50]) resulting in the increase in the activity of MMP-1 and MMP-9.

It is clear that due to the high incidence of infection driven PTB, including those with pPROM, the role of TLR and their ligands in the fetal membranes with and without chorioamnionitis has been the subject of some study. To date, only a few papers have produced data linking DAMPs (as opposed to PAMPs) and the fetal membranes. These have mostly focused on the production of HMGB1, which has been confirmed to increase in amniotic fluid of human fetal membranes with pPROM ([@B138]), and is induced by intrauterine infection with LPS, in sheep ([@B132]). Even though much of the current work that is focused on DAMPs in the fetal membranes is AEC centric, the data provides strong evidence that DAMP production by AMC would produce inflammation, perhaps in an autocrine fashion, and this would likely influence the integrity of the amnion. In addition, DAMPs are produced by many of the other cells important for the maintenance of pregnancy ([@B125]; [@B109]). They could also activate AMC in a paracrine fashion and contribute to the increase in inflammation and MMPs, which could ultimately lead to membrane rupture.

DAMP/PAMP PRR Pathway Manipulation: Potential Therapeutic Strategies for Fetal Membrane Maintenance {#S7}
===================================================================================================

There are a multitude of developing therapies based on PRRs recognition of their ligands for the resolution of diseases with an inflammatory signature. Indeed, in other disease and disorder fields like sepsis for example, DAMP manipulation is being tested by the antagonism of HMGB1 ([@B181]). Although this body of work is expansive, it will not be focused on here as it would warrant its own focused review article. Here we aim to describe the studies that have been specifically focused on the manipulation of this pathway in the tissues of pregnancy, including the fetal membranes where possible, and therefore show promise for future development of strategies to address the maintenance of the integrity of this tissue ([Figure 2](#F2){ref-type="fig"}).

Signaling events activated by the DAMP and PAMP ligands are numerous, and complex, with an ever-expanding repertoire of players. Some of these molecules overlap between pathways, while others are more specific. This broad network provides numerous potential targets for manipulation and his has been explored due to their potential for other causes of PTB, but rarely for their direct effects on the fetal membranes. This is because it is highly likely that DAMPs and PAMPs working through their PRRs also have a role in myometrial activation and cervical ripening. This body of work has provided some exciting data ([Figure 2](#F2){ref-type="fig"}) that may be used to help us discern the ability for some of the already tested strategies, or develop novel ones, that could be used to help manipulate the timing of membrane rupture too.

It has been suggested that anti-TLR monoclonal antibodies could be good therapeutic target to decrease inflammation driven adverse perinatal outcomes ([@B178]) and thus it should be considered whether they may also serve as good PTB therapies. Indeed, neutralizing antibodies against TLR4 reduce the percentages of decidual invariant natural killer cells, decreasing inflammation ([@B78]). Soluble TLRs have also been suggested as potential markers or treatment sites for those conditions where they are understood to have a key role ([@B1]). However, it still remains to see their effects elsewhere in the other tissues when pregnant. An alternative strategy in the same vein has been to use soluble RAGE as a therapeutic tool to decrease inflammation. Pretreatment with these inhibited LPS-induced preterm uterine contractility, cytokines, and prostaglandins in Rhesus monkeys ([@B169]), supporting the premise that this approach has merit for further exploration in pregnancy.

An alternate approach designed to target pathways more specifically has been to knockdown downstream signaling for the PRRs. Interferon regulatory factor (IRF) 5 knockdown leads to less inflammation in myometrium ([@B79]) and thus inhibitors for IRF1 have also been suggested as a therapeutic strategy due to their direct role in TLR signaling ([@B82]). Other studies testing the potential of TLR4 inhibitors have been successful at decreasing levels of inflammation associated with its activation. Indeed, levels of Tollip, an inhibitor of TLR4 that is known to correlate with PE severity ([@B113]) and the TLR4 antagonist (+)-naloxone ([@B27]) were shown to suppress cytokine expression. Although these studies were performed in the placenta and myometrium/decidua, respectively, they provide promising data for developing this approach in fetal membranes.

Other work has focused specifically on PAMP stimulated TLR response manipulation. Thus, several different biomolecules have been shown to inhibit inflammation or PTB in animal models due to their ability to decrease TLR ligand induced responses. Surfactant-A intrauterine injection was found to significantly decrease TLR ligand induced inflammation and inhibit preterm delivery via TLR2 ([@B2]). As GSK3 α and β activity is increased in fetal membranes after labor, the GSK3β inhibitor CHIR99021 was tested and found to decrease LPS stimulated pro-inflammatory cytokines, TNFα, IL-1β, IL-6, IL-8, prostaglandins and MMP-9 in myometrial cells and fetal membranes cells ([@B80]). In addition, the protein Pellino 1 was shown to regulate TLR and TNF signaling, by decreasing TLR2/6, TLR3, TLR5 and the pro-inflammatory cytokines IL-8, IL-1β, and IL-6 ([@B79]). When the addition of Tim3 was tested, it was found to protect decidual cells from TLR extracellular signal-regulated protein kinase 1 and 2 (ERK1/2) dependent apoptosis and inflammation ([@B173]).

Decreases in TLR signaling by the removal of their key partners or decreasing receptor numbers have also been studied. The elimination of Mincle, a sensor for lipids, was shown to lead to decreased effect of TLR ligands to cause inflammation in uterus ([@B81]). In addition, GIT2 knockdown, in myometrial and amnion cells also lead to decreased inflammation in response to TLR ligands ([@B81]). The P2X7 receptor, which has been shown to regulate IL-1β release from gestational tissues working in concert with TLRs has also been studied. The inflammation it produced on stimulation with a specific receptor agonist, was inhibited by the progesterone, prolactin and an NF-κB inhibitor ([@B89]). Finally, treatment with 15-deoxy-delta-12, 14-prostaglandin J2 (15d-PGJ2) affected TLR4 by blocking its NF-κB induced inflammation, reducing preterm labor in a mouse model ([@B126]).

It remains to be seen how the further development of these potential therapeutic targets will continue. With such a large number of signaling pathways, receptors and ligands involved, there are many other targets that are yet to be investigated. However, which of the manipulated mechanisms will have too many unwanted effects, or that have an unwanted global biological effect on other organs and the fetus, remains to be determined. Regardless, interest in these pathways is gathering momentum due to their potential to increase our understanding of the mechanisms at play and to prevent the rupture of the membranes. Due to their central role in infection and non-infection driven inflammation, they also have enormous potential for treatments for the other etiologies of PTB ([@B33]).

Summary {#S8}
=======

The trigger that initiates tissue remodeling in preparation for parturition remains elusive. This missing stimulus includes that which activates the weakening cascade of the fetal membranes in preparation for its rupture. Understanding this is not only important to determine what happens in normal pregnancy but also because the timing of this event is crucial for healthy pregnancy outcomes. If rupture does not occur in a timely fashion it can result in pROM or pPROM leaving the fetus vulnerable to infection and distress. It can also precipitate PTB, as pPROM is evident in approximately one third of all cases of premature delivery. It is currently thought that the change that may switch on the process of membrane weakening is an increase in cellular stress. This is already known to increase toward the end of gestation in the form of physical distension of the fetal membrane tissue and also the build-up of ROS. It is well established that DAMPs are generated by many forms of cell stress and their general biological function is to raise the alarm within tissues. They do this by producing a number of pro-inflammatory cytokines, MMPs and often lead to apoptosis. They accomplish this through their interaction with numerous PRRs and their downstream signaling pathways, often achieving their influence on inflammation by activating the transcription factor NF-κB. Much of what we understand about the role of DAMPs, especially in the fetal membranes, comes from work in other tissue types or from consideration of data from PAMP ligand action. This is because these ligands also work through many of the same PRRs. However, these data should be viewed with caution; PAMPs and DAMPs have been seen to result in differential signaling through the same PRR. Despite this, numerous similarities that have been described in their actions. PAMPs are well established to cause infection driven membrane rupture, and so it is tempting to postulate that the DAMP counterparts are also able to do this. These molecules could therefore be the link between the biophysical and biochemical changes that happen toward term to weaken the fetal membranes. This idea has been least studied from the perspective of understanding the ECM DAMPs. Perhaps this is because they are one of the more difficult molecules to study in this tissue, given that most researchers are working on it at in term state when much of the ECM has already started to breakdown. Thus, we need to build new models to study the interaction and generation of ECM DAMPs with the AMC within this layer of the amnion. There have been several studies that have focused on understanding the potential of the manipulation of the DAMP, PAMP, PRR system, with an eye to future therapies for various PTB etiologies. Although still in their infancy, it is tempting to speculate that more work focused in this vein will indeed not only solidify the key role of these molecules in parturition, but provide much needed prevention and identification biomolecular targets to help us address the high rates of PTB in the United States.
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a2V

:   V-ATPase

ADAMTS5

:   ADAM metallopeptidase with Thrombospondin type 1 motif 5
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:   amnion epithelial cell
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:   amnion mesenchymal cell

AP1

:   Activator protein 1
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:   Adenosine tri-phosphate
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cffDNA
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CLR

:   C-type lectin receptors

DAMP

:   Danger associated molecular pattern
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:   Dendritic cell natural killer lectin group receptor-1

dsRNA
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:   high mobility group box 1
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:   interferon
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:   Interleukin
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IRF

:   IFN regulatory factors
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LMW
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LPS
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:   MyD88 adaptor-like protein
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MMP

:   Matrix Metalloproteinase
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MYD88

:   myeloid differentiation primary response protein 88

NF-kB

:   Nuclear Factor Kappa B

NLR
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NLRP3

:   LRR- and pyrin domain-containing protein 3

P2YR
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P2X7R
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:   Pattern associated molecular pattern

PBMC

:   peripheral blood mononuclear cell

PBS

:   phosphate buffered saline
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:   prostaglandin E2
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:   peptidoglycan

Poly I:C

:   polyinosinic-polycytidylic
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:   preterm premature rupture of the membranes

PRRs

:   Pattern recognition receptors

PTB

:   Preterm birth

PTL

:   Preterm labor
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:   advanced glycation end products

RANTES, regulated upon activation

:   normal T expressed and secreted

RD

:   repressor domain

RLR

:   RIG-1-like receptors
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:   reactive oxygen species

SAA1

:   serum amyloid A1
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:   sin3A associated protein 3A

SASP

:   senescence-associated secretory phenotype

ssRNA

:   single stranded ribonucleic acid

ST2

:   suppression of tumorigenicity 2

TIM

:   T-cell immunoglobulin and mucin-containing domain-3

TIR

:   Toll/IL1 receptor

TLR

:   Toll-like receptors

TNF

:   tumor necrosis factor

TRAM

:   TIR domain-containing adapter molecule 2

TRIF
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